封面
市场调查报告书
商品编码
1747305

动物麻醉剂市场:依麻醉剂类别、按动物类型、按给药途径、按应用、按分销管道、按最终用户、按地区

Veterinary Anesthesia Drugs Market, By Anesthetic Drug Class, By Animal Type, By Route of Administration, By Application, By Distribution Channel, By End User, By Geography

出版日期: | 出版商: Coherent Market Insights | 英文 166 Pages | 商品交期: 2-3个工作天内

价格
简介目录

2025 年全球兽医麻醉剂市场规模估计为 5.112 亿美元,预计到 2032 年将达到 7.892 亿美元,2025 年至 2032 年的复合年增长率为 6.4%。

报告范围 报告详细信息
基准年 2024 2025年的市场规模 5.112亿美元
效能数据 2020-2024/td> 预测期 2025-2032
预测期:2025-2032年复合年增长率: 6.40% 2032年价值预测 7.892亿美元

近年来,全球兽医麻醉剂市场经历了显着增长,这得益于对先进兽医治疗的需求不断增长以及伴侣动物慢性病患病率上升。兽医麻醉剂在各种外科手术中发挥着至关重要的作用,确保动物在医疗干预过程中的安全和舒适。这些药物用于诱导和维持麻醉,提供疼痛缓解和肌肉放鬆,使兽医能够执行复杂的外科手术和诊断程序。这个市场包括各种各样的麻醉剂,包括麻醉剂、麻醉剂和局部麻醉剂,每种麻醉药都有其独特的特性和应用。随着全球宠物拥有量持续成长,以及饲主更愿意为他们心爱的动物投资先进的医疗保健,预计未来几年对兽医麻醉剂的需求将进一步扩大。

市场动态

全球兽医麻醉剂市场受多种关键因素影响,这些因素推动其成长、带来挑战并带来机会。主要驱动因素之一是宠物数量的增长以及饲主愿意为宠物投资优质医疗服务,从而推动了对先进兽医治疗的需求不断增长。此外,伴侣动物中癌症、心血管疾病和整形外科疾病等慢性疾病的发生率不断上升,导致外科手术数量增加,进一步刺激了对兽医麻醉剂的需求。然而,该市场也存在一些限制因素,例如麻醉剂和麻醉设备成本高昂,这可能会限制其在成本敏感地区的应用。此外,缺乏标准化的兽医麻醉剂通讯协定以及某些麻醉剂的潜在副作用也可能对市场成长构成挑战。儘管存在这些市场限制因素,但该市场仍为製造商和供应商提供了巨大的机会。创新和安全的麻醉剂的开发以及对微创外科手术的日益关注预计将推动市场扩张。此外,新兴经济体对兽医麻醉剂的需求不断增长,加上兽医医院和诊所网路的不断扩大,为市场参与者提供了丰厚的成长前景。

本研究的主要特点

  • 本报告对全球兽医麻醉剂市场进行了详细分析,并提供了预测期(2025-2032)的市场规模和年复合成长率(CAGR%),假设 2024 年为基准年。
  • 它揭示了不同领域的潜在商机,并解释了该市场的有吸引力的投资提案矩阵。
  • 它还提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景和主要企业采用的竞争策略的重要见解。
  • 全球动物麻醉剂市场的主要企业是根据公司亮点、产品系列、关键亮点、财务绩效和策略等参数进行的分析。
  • 本报告的见解将使负责人和公司经营团队能够就未来的产品发布、类型升级、市场扩张和行销策略做出明智的决策。
  • 全球动物麻醉剂市场报告针对该行业的各个相关人员,包括投资者、供应商、产品製造商、经销商、新进业者和金融分析师。
  • 相关人员将透过用于分析全球动物麻醉剂市场的各种策略矩阵更轻鬆地做出决策。

目录

第一章 研究目的与前提

  • 研究目标
  • 先决条件
  • 简称

第二章 市场展望

  • 报告描述
    • 市场定义和范围
  • 执行摘要

第三章市场动态、法规与趋势分析

  • 市场动态
  • 驱动程式
  • 限制因素
  • 机会
  • 影响分析
  • 主要进展
  • 监管情景
  • 产品发布/核准
  • PEST分析
  • 波特分析
  • 併购场景
  • 产业趋势

4. 2020 年至 2032 年全球动物麻醉剂市场(依麻醉剂类别划分)

  • 全身麻醉
  • 巴比妥类药物
  • 解离剂(例如氯胺酮)
  • 吸入剂(例如Isoflurane、SEVOFLURANE)
  • 局部麻醉剂
  • Lidocaine
  • Bupivacaine
  • 佐剂
  • 镇静剂(例如Dexmedetomidine、美托咪啶)
  • 止痛药(例如鸦片类药物、非类固醇抗发炎药)
  • 神经肌肉阻断剂

5. 2020 年至 2032 年全球动物麻醉剂市场(依动物类型)

  • 伴侣动物
  • 家畜

6. 2020 年至 2032 年按给药途径分類的全球动物麻醉剂市场

  • 静脉
  • 肌肉注射
  • 吸入
  • 局部的
  • 其他(术前口服镇静剂)

7. 2020 年至 2032 年全球动物麻醉剂市场(按应用)

  • 外科手术
  • 诊断程序
  • 疼痛管理

8. 2020 年至 2032 年全球动物麻醉剂市场(依通路划分)

  • 动物用药品店
  • 网路药局
  • 零售药局

9. 2020 年至 2032 年全球动物麻醉剂市场(依最终使用者划分)

  • 医院/诊所
  • 学术和研究机构
  • 流动兽医队
  • 其他的

第 10 章全球动物麻醉剂市场(按地区划分,2020-2032 年)价值

  • 北美洲
      • 美国
      • 加拿大
  • 拉丁美洲
      • 巴西
      • 阿根廷
      • 墨西哥
      • 其他拉丁美洲
  • 欧洲
      • 德国
      • 英国
      • 西班牙
      • 法国
      • 义大利
      • 俄罗斯
      • 其他欧洲国家
  • 亚太地区
      • 中国
      • 印度
      • 日本
      • 澳洲
      • 韩国
      • ASEAN
      • 其他亚太地区
  • 中东
      • 海湾合作委员会国家
      • 以色列
      • 其他中东地区
  • 非洲
      • 南非
      • 北非
      • 中部非洲

第十一章竞争格局

  • Zoetis
  • Merck Animal Health
  • Elanco
  • Bayer Animal Health
  • Vetoquinol
  • Dechra Pharmaceuticals
  • Cegelec
  • Jorgensen Laboratories
  • Abaxis
  • VetMedin
  • Henry Schein Animal Health
  • MWI Animal Health
  • IDEXX Laboratories
  • Neogen Corporation
  • Virbac

第十二章 分析师建议

  • 命运之轮
  • 分析师观点
  • Coherent Opportunity Map

第十三章参考文献与调查方法

  • 参考
  • 调查方法
  • 关于出版商
简介目录
Product Code: CMI7971

Global Veterinary Anesthesia Drugs Market is estimated to be valued at USD 511.2 Mn in 2025 and is expected to reach USD 789.2 Mn by 2032, growing at a compound annual growth rate (CAGR) of 6.4% from 2025 to 2032.

Report Coverage Report Details
Base Year: 2024 Market Size in 2025: USD 511.2 Mn
Historical Data for: 2020 To 2024 Forecast Period: 2025 To 2032
Forecast Period 2025 to 2032 CAGR: 6.40% 2032 Value Projection: USD 789.2 Mn

The global veterinary anesthesia drugs market has witnessed significant growth in recent years, driven by the increasing demand for advanced veterinary care and the rising prevalence of chronic diseases among companion animals. Veterinary anesthesia drugs play a crucial role in various surgical procedures, ensuring the safety and comfort of animals during medical interventions. These drugs are used to induce and maintain anesthesia, providing pain relief and muscle relaxation, enabling veterinarians to perform complex surgeries and diagnostic procedures. The market encompasses a wide range of anesthetic agents, including injectable anesthetics, inhalation anesthetics, and local anesthetics, each with unique properties and applications. As pet ownership continues to rise globally and pet owners become more willing to invest in advanced healthcare for their furry companions, the demand for veterinary anesthesia drugs is expected to grow further in the coming years.

Market Dynamics

The global veterinary anesthesia drugs market is influenced by several key factors that drive its growth, pose challenges, and present opportunities. One of the primary drivers is the increasing demand for advanced veterinary care, fueled by the growing pet population and the willingness of pet owners to invest in high-quality medical treatments for their animals. Moreover, the rising prevalence of chronic diseases among companion animals, such as cancer, cardiovascular disorders, and orthopedic conditions, has led to a higher number of surgical procedures, further boosting the demand for veterinary anesthesia drugs. However, the market also faces certain restraints, including the high cost of anesthetic drugs and equipment, which can limit their adoption in cost-sensitive regions. Additionally, the lack of standardized protocols for veterinary anesthesia and the potential side effects associated with certain anesthetic agents may pose challenges to market growth. Despite these restraints, the market presents significant opportunities for manufacturers and suppliers. The development of innovative and safer anesthetic drugs, along with the increasing focus on minimally invasive surgical techniques, is expected to drive market expansion. Furthermore, the growing demand for veterinary anesthesia drugs in emerging economies, coupled with the expanding network of veterinary clinics and hospitals, offers lucrative growth prospects for market players.

Key Features of the Study

  • This report provides in-depth analysis of the global veterinary anesthesia drugs market, and provides market size (USD Million) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global veterinary anesthesia drugs market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Zoetis, Merck Animal Health, Elanco, Bayer Animal Health, Vetoquinol, Dechra Pharmaceuticals, Cegelec, Jorgensen Laboratories, Abaxis, VetMedin, Henry Schein Animal Health, MWI Animal Health, IDEXX Laboratories, Neogen Corporation, and Virbac
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global veterinary anesthesia drugs market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global veterinary anesthesia drugs market

Market Segmentation

  • Anesthetic Drug Class Insights (Revenue, USD Mn, 2020 - 2032)
    • General Anesthetics
    • Barbiturates
    • Dissociative Agents (e.g., Ketamine)
    • Inhalant Agents (e.g., Isoflurane, Sevoflurane)
    • Local Anesthetics
    • Lidocaine
    • Bupivacaine
    • Adjunctive Agents
    • Sedatives (e.g., Dexmedetomidine, Medetomidine)
    • Analgesics (e.g., Opioids, NSAIDs)
    • Neuromuscular Blockers etc.
  • Animal Type Insights (Revenue, USD Mn, 2020 - 2032)
    • Companion Animals
    • Livestock Animals
  • Route of Administration Insights (Revenue, USD Mn, 2020 - 2032)
    • Intravenous
    • Intramuscular
    • Inhalation
    • Topical
    • Others (Oral-pre-surgical sedation)
  • Application Insights (Revenue, USD Mn, 2020 - 2032)
    • Surgical Procedures
    • Diagnostic Procedures
    • Pain Management
  • Distribution Channel Insights (Revenue, USD Mn, 2020 - 2032)
    • Veterinary Drug Stores
    • Online Pharmacies
    • Retail Pharmacies
  • End User Insights (Revenue, USD Mn, 2020 - 2032)
    • Hospitals/Clinics
    • Academic & Research Institutes
    • Mobile Veterinary Units
    • others
  • Regional Insights (Revenue, USD Mn, 2020 - 2032)
    • North America
    • U.S.
    • Canada
    • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
    • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
    • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
    • Middle East
    • GCC Countries
    • Israel
    • Rest of Middle East
    • Africa
    • South Africa
    • North Africa
    • Central Africa
  • Key Players Insights
    • Zoetis
    • Merck Animal Health
    • Elanco
    • Bayer Animal Health
    • Vetoquinol
    • Dechra Pharmaceuticals
    • Cegelec
    • Jorgensen Laboratories
    • Abaxis
    • VetMedin
    • Henry Schein Animal Health
    • MWI Animal Health
    • IDEXX Laboratories
    • Neogen Corporation
    • Virbac

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Global Veterinary Anesthesia Drugs Market, By Anesthetic Drug Class
    • Global Veterinary Anesthesia Drugs Market, By Animal Type
    • Global Veterinary Anesthesia Drugs Market, By Route of Administration
    • Global Veterinary Anesthesia Drugs Market, By Application
    • Global Veterinary Anesthesia Drugs Market, By Distribution Channel
    • Global Veterinary Anesthesia Drugs Market, By End User
    • Global Veterinary Anesthesia Drugs Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
  • Driver
  • Restraint
  • Opportunity
  • Impact Analysis
  • Key Developments
  • Regulatory Scenario
  • Product Launches/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario
  • Industry Trends

4. Global Veterinary Anesthesia Drugs Market, By Anesthetic Drug Class, 2020-2032, (USD Mn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • General Anesthetics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Barbiturates
  • Dissociative Agents (e.g., Ketamine)
  • Inhalant Agents (e.g., Isoflurane, Sevoflurane)
  • Local Anesthetics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Lidocaine
  • Bupivacaine
  • Adjunctive Agents
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Sedatives (e.g., Dexmedetomidine, Medetomidine)
  • Analgesics (e.g., Opioids, NSAIDs)
  • Neuromuscular Blockers

5. Global Veterinary Anesthesia Drugs Market, By Animal Type, 2020-2032, (USD Mn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Companion Animals
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Livestock Animals
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

6. Global Veterinary Anesthesia Drugs Market, By Route of Administration, 2020-2032, (USD Mn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Intravenous
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Intramuscular
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Inhalation
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Topical
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Others(Oral-pre-surgical sedation)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

7. Global Veterinary Anesthesia Drugs Market, By Application, 2020-2032, (USD Mn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Surgical Procedures
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Diagnostic Procedures
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Pain Management
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

8. Global Veterinary Anesthesia Drugs Market, By Distribution Channel, 2020-2032, (USD Mn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Veterinary Drug Stores
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Online Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Retail Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

9. Global Veterinary Anesthesia Drugs Market, By End User, 2020-2032, (USD Mn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Hospitals/Clinics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Academic & Research Institutes
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Mobile Veterinary Units
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

10. Global Veterinary Anesthesia Drugs Market, By Region, 2020 - 2032, Value (USD Mn)

  • Introduction
    • Market Share (%) Analysis, 2025, 2028 & 2032, Value (USD Mn)
    • Market Y-o-Y Growth Analysis (%), 2021 - 2032, Value (USD Mn)
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, By Anesthetic Drug Class, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Animal Type, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
      • U.S.
      • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, By Anesthetic Drug Class, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Animal Type, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
      • Brazil
      • Argentina
      • Mexico
      • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, By Anesthetic Drug Class, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Animal Type, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
      • Germany
      • U.K.
      • Spain
      • France
      • Italy
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, By Anesthetic Drug Class, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Animal Type, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, By Anesthetic Drug Class, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Animal Type, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
      • GCC Countries
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, By Anesthetic Drug Class, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Animal Type, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Country/Region, 2020 - 2032, Value (USD Mn)
      • South Africa
      • North Africa
      • Central Africa

11. Competitive Landscape

  • Zoetis
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Merck Animal Health
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Elanco
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Bayer Animal Health
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Vetoquinol
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Dechra Pharmaceuticals
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Cegelec
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Jorgensen Laboratories
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Abaxis
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • VetMedin
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Henry Schein Animal Health
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • MWI Animal Health
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • IDEXX Laboratories
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Neogen Corporation
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Virbac
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies

12. Analyst Recommendations

  • Wheel of Fortune
  • Analyst View
  • Coherent Opportunity Map

13. References and Research Methodology

  • References
  • Research Methodology
  • About us